Real-World clinical outcomes of asthma patients switched from reslizumab to mepolizumab or benralizumab

Overview of attention for article published in Frontiers in Allergy, January 2023

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 6 Mendeley

So far, Altmetric has seen 1 X post from an account with 1,134 followers.

New Research: Real-World clinical outcomes of asthma patients switched from reslizumab to mepolizumab or benralizumab https://t.co/pxFidmycwb #Allergy

04 Jan 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.